LAUNCH News
Anthropic Launches Claude Science, Initiates Drug Discovery Programs
Anthropic has introduced Claude Science, an AI workbench tailored for scientific research in biopharma, now available to its enterprise customers. Concurrently, the company announced its initiative to
China Breaks Ground on First AI-Assisted Personalized Tumor Vaccine Production Line
Likang Life Sciences has started construction on China's first AI-assisted production line for personalized tumor vaccines in Beijing, with a total investment of approximately US$16.1 million. This in
Largest chemical reactions database launched to boost AI drug discovery
Researchers at the University of Michigan have introduced the largest open-access repository of carbon-nitrogen bond-forming reactions. This new database aims to address critical data gaps in AI-assis
NVIDIA Launches BioNeMo Agent Toolkit for AI-Driven Drug Discovery
NVIDIA unveiled its BioNeMo Agent Toolkit at BIO USA 2026, extending agentic AI capabilities from coding to intricate scientific workflows in life sciences. This platform aims to automate multi-step t
NVIDIA Launches BioNeMo Agent Toolkit to Accelerate Scientific Discovery in Life Sciences
NVIDIA has introduced its BioNeMo Agent Toolkit, a complete suite of AI tools and skills designed to let AI agents to perform complex scientific workflows across biology, chemistry, genomics,
Genomics Launches AI Platform Mystra AI to Simplify Drug Discovery
Mystra AI, a new AI platform from biotech company Genomics, aims to significantly improve drug discovery and validation. The platform leverages a vast database of genotype-phenotype information to pre
Genesis AI Unveils Eno Humanoid Robot for Advanced Lab Automation
Genesis AI has launched Eno, a new humanoid robot designed to perform complex tasks with high precision, including lab automation. Departing from traditional human-like aesthetics, Eno features a mini
China Launches World's First Commercial Brain Chip, Surpassing Neuralink
China has approved the world's first commercially available brain chip, NEO, following successful clinical trials. Developed by researchers at Beijing's Tsinghua University and Shanghai-based Neuracle
Ainnocence Launches Production-Ready Protein, Antibody, and Peptide AI Models via APIs
Ainnocence, a next-generation AI drug discovery company, has announced the production launch of its core protein-AI models as secure, on-demand APIs. This allows pharmaceutical and biotechnology partn
China Approves World's First Commercial Invasive Brain-Computer Interface
China's National Medical Products Administration has granted commercial marketing approval to Neuracle Medical Technology for its invasive brain-computer interface (BCI) system, making it the first su
Ginkgo Bioworks Pioneers AI-Powered Autonomous Labs for Rapid Drug Discovery
Ginkgo Bioworks is transforming scientific research by deploying autonomous laboratories where AI-powered robots conduct experiments, significantly cutting costs and accelerating discovery. This innov
Genomics Launches Mystra AI Platform for Drug Discovery and Validation
Genomics, a Techbio company, has launched its Mystra AI platform, an agentic AI platform focused on supercharging drug target discovery and validation. The platform leverages the world's largest human
Tempus AI Launches Next-Gen Genetic Test for Oncology
Tempus AI has announced the upcoming launch of its xH test, a next-generation genetic test for oncology. This whole-genome sequencing assay aims to detect actionable oncologic targets in blood and bon
Chinese Supercomputer AI Platform Slashes Drug Screening Time
China has unveiled GalaxyVS, an AI platform powered by new-generation Tianhe supercomputers, dramatically reducing initial drug screening from months or years to tens of seconds. Developed by the Nati
Tempus Unveils Next-Gen Lens: Agentic AI for Oncology Drug Development
Tempus AI has launched the next-generation of its Lens platform, an agentic AI system designed to accelerate oncology drug development and research. This updated platform integrates multimodal data, A
Tempus Introduces 'Preview' to Accelerate Oncology Diagnostic Insights with AI
Tempus AI, Inc. Has launched Tempus Preview, an AI-powered application designed to provide rapid, clinically significant insights in precision oncology. This new tool aims to close the critical time g
Microsoft Launches Copilot Health for AI-Powered Personal Health Management
Microsoft has launched a preview version of Copilot Health, an AI-powered platform designed to aggregate users' health records and wearable device data into a single, complete profile. This tool,
Samsung Medical Center to Lead AI Surgical Robot Development with Government Funding
Samsung Medical Center has been selected to lead a new Ministry of Health and Welfare project, securing approximately 10 billion won (around $7.3 million USD) in government funding over five year
Chan Zuckerberg Biohub Unveils AI 'World Model' for Protein Design
The Chan Zuckerberg Biohub, a philanthropic venture by Mark Zuckerberg and Dr. Priscilla Chan, has launched an open-source AI 'world model' of protein biology. This model aims to accelerate drug disco
Ginkgo, Tangible Scientific, Inductive Bio Launch ADME-One™ for AI Drug Discovery
Ginkgo Bioworks, in partnership with Tangible Scientific and Inductive Bio, has launched ADME-One™, an integrated AI-powered platform designed to bring pharmacokinetic projection earlier into the drug
Perceptic Launches AI Operating System for Drug Development with $12M Seed Funding
Perceptic, an AI operating system for biopharma, has emerged from stealth with a $12M seed funding round led by Air Street Capital and Accel. Built by former Palantir AIP team members, the platform is
Kordata Dynamics Launches AI-Powered Precision Clinical Trials Platform with Pre-Seed Backing
Kordata Dynamics has emerged from stealth, launching an AI-powered precision clinical trials platform aimed at enhancing the speed, quality, and accessibility of clinical research. The company also se
Tempus Launches ArteraAI Prostate Test for Metastatic Patients
Tempus AI, a leader in artificial intelligence and precision medicine, has launched the ArteraAI Prostate Test (mHSPC) for clinical use. This CLIA-certified and CAP-accredited prognostic test, the fir
QIAGEN Launches QIA Agent for AI-Driven Scientific Guidance in Labs
QIAGEN has introduced QIA Agent, an AI-powered conversational tool designed to simplify how researchers access scientific information, product selection, and operational support within their Sample
IBM Research Unveils Open Biomedical AI Foundation Model MAMMAL
IBM Research has launched MAMMAL, a multimodal biomedical foundation model, making it openly available for research. Trained on approximately 2 billion biological samples, MAMMAL integrates proteins,
LLM Tool Boosts Phase III Trial Enrollment for Polycythemia Vera
Synapsis AI, a medically trained large language model, significantly reduced patient screening burdens and improved enrollment in a randomized, interventional Phase III clinical trial for polycythemia
Genesis AI Unveils GENE-26.5 Robotic System, Secures $105M Seed Funding
Genesis AI has launched its GENE-26.5 robotic manipulation system, featuring a human-scale dexterous hand designed for intricate tasks, including lab pipetting. The company also announced a significan
Insilico Medicine Unveils LabClaw for Autonomous AI Drug Discovery
Insilico Medicine, a generative AI-driven drug discovery company, announced the launch of LabClaw, an intelligent laboratory operating system. This system is designed to complement Insilico's fully au
Japan Opens Robotics Innovation Center, Deploys AI for Medical Diagnostics
The Institute of Science Tokyo has launched a new Robotics Innovation Center, housing Maholo humanoid robots developed with AIST and Yaskawa Electric, capable of performing up to 1,000 experiments 24/
Zuckerberg's Biohub Launches $500M Initiative for AI-Driven Cell Models
The Biohub, co-chaired by Mark Zuckerberg, has announced the Virtual Biology Initiative, committing $500 million to create massive biological datasets and develop AI models capable of simulating human
Motif Neurotech Gets FDA Greenlight for Depression BCI Trial
Motif Neurotech, a brain-computer interface (BCI) company focused on mental health, has received FDA approval for an Investigational Device Exemption (IDE) to begin the RESONATE Early Feasibility Stud
Lantern Pharma Expands predictBBB.ai into Global AI Drug Discovery Platform
Lantern Pharma Inc. Has transformed its predictBBB.ai platform into a Large Quantitative Model (LQM), a real-time quantitative intelligence engine accessible globally via a single browser interface. T
Generative AI Leap: Insilico Medicine Nominates First Preclinical Candidate in UAE
Insilico Medicine, an AI-driven drug discovery company, has nominated ISM0387 as its first preclinical candidate discovered entirely in the UAE. The MTA-cooperative PRMT5 inhibitor for glioblastoma wa
OpenAI Launches GPT-Rosalind to Accelerate Drug Discovery
OpenAI has introduced 'GPT-Rosalind,' its first AI model tailored for accelerating early-stage research in biology, drug discovery, and translational medicine. Named after chemist Rosalind Franklin, t
OpenAI unveils GPT-Rosalind to accelerate AI drug discovery and biology research
OpenAI has launched "GPT-Rosalind," its first AI model designed to speed up early-stage research in biology, drug discovery, and translational medicine. This new reasoning model aims to address ineffi
AWS Launches Amazon Bio Discovery to Speed AI Drug Development
Amazon Web Services has introduced Amazon Bio Discovery, an AI-powered application designed to accelerate drug development. The platform provides scientists with direct access to specialized biologica
OpenAI Launches GPT-Rosalind AI Model for Drug Discovery and Life Sciences Research
OpenAI has unveiled GPT-Rosalind, a new domain-specific AI model designed to accelerate drug discovery and translational medicine. This model is tailored for complex biological research workflows, aim
Amazon Launches AI-Driven Bio Discovery Platform on AWS
Amazon Web Services (AWS) has launched its new AI-driven platform, Amazon Bio Discovery, to accelerate early-stage drug discovery for pharmaceutical and biotechnology industries. The platform integrat
OpenAI Unveils GPT-Rosalind AI Model for Accelerated Drug Discovery
OpenAI has launched GPT-Rosalind, a new AI model specifically designed for scientists in drug discovery, biology, and medical research. This specialized system integrates with over 50 daily scientific
OpenAI Debuts GPT-Rosalind AI Model for Accelerated Drug Discovery
OpenAI has launched GPT-Rosalind, an artificial intelligence model designed to significantly speed up drug discovery and scientific research, focusing on life sciences. This new model is optimized for
Caris Life Sciences Launches AI-Powered Molecular Insight for NSCLC Treatment
Caris Life Sciences has introduced a new AI-driven molecular insight designed to help identify whether adding chemotherapy benefits or harms non-small cell lung cancer (NSCLC) patients eligible for mo
Medtronic's AI Surgical System Gains FDA Clearance for Cranial & ENT
Medtronic has announced U.S. Food and Drug Administration (FDA) clearance for its AI-enabled Stealth AXiS surgical system, expanding its use to cranial and ear, nose, and throat (ENT) procedures. The
Basecamp Research Launches Trillion Gene Atlas for AI-Designed Therapeutics
Basecamp Research, in collaboration with Anthropic, Ultima Genomics, PacBio, and powered by NVIDIA AI, has launched the Trillion Gene Atlas. This initiative aims to expand known evolutionary genetic d
Persistent, NVIDIA Launch AI Generative Molecules & Virtual Screening Solution
Persistent Systems has partnered with NVIDIA to introduce a new AI-powered solution for generative molecules and virtual screening, aiming to accelerate early-stage drug discovery for healthcare and l
PerturbAI Launches from Stealth with World's Largest In Vivo CRISPR Atlas
PerturbAI, an AI-native therapeutics company, emerged from stealth on March 17, 2026, announcing the public release of the world's largest in vivo CRISPR atlas. This extensive 8 million-cell, brain-wi
Roche Scales NVIDIA AI Factories Globally to Accelerate Drug Discovery & Diagnostics
Roche is deploying over 3,500 NVIDIA Blackwell GPUs across its global operations, significantly expanding its AI infrastructure to accelerate drug discovery, diagnostic solutions, and manufacturing ef
Micro CRISPR: Revolutionizing Biotech with AI-Driven Speed
Micro CRISPR, a new biotech company spun out of Meril Life Sciences, is pioneering an AI-driven approach to drug discovery. The company aims to combine the rapid pace of technology with rigorous scien
Kala Bio to Deploy First Commercial AI Agent for Biotech R&D in 14 Days
Kala Bio, in collaboration with Younet.ai, announced it is ready to ship its first commercial AI agent from the rebranded Researgency.ai platform within approximately 14 days. This strategic move tran
Kala Bio Launches Researgency.ai, Pivots to AI for Biotech Operations
Kala Bio (NASDAQ: KALA) has launched its enterprise AI platform, Researgency.ai, marking a strategic shift to become a dual-engine company combining its drug pipeline with a scalable AI product. The c
LabVantage Solutions Introduces AI-Driven CORTEX Platform
LabVantage Solutions, a global provider of laboratory informatics, has launched LabVantage CORTEX, a new AI, analytics, and automation platform. This cloud-native platform integrates advanced AI and s
LabVantage Launches CORTEX for AI-Driven Lab Operations
LabVantage Solutions has introduced LabVantage CORTEX, an advancement to its LIMS platform that integrates agentic AI and cloud-native automation to enhance laboratory efficiency, reduce errors, and p
Cellarity Unveils AI Platform for Cell-Targeting Drug Discovery
Cellarity, a Flagship Pioneering company, has launched an new AI platform designed to discover and develop cell-targeted medicines. This platform leverages proprietary AI models to analyze comp
Eli Lilly Launches World's Most Powerful AI Factory for Drug Discovery
Eli Lilly has launched "LillyPod," an AI factory powered by over 1,000 NVIDIA Blackwell Ultra GPUs, making it the most powerful AI supercomputer owned by a pharmaceutical company. This initiative aims